NCT05004155

Brief Summary

GERD is common in Indian population and the normative data which is used to diagnose \& manage GERD and its complications are based on western data which is not validated in the Indian population. Although normative data is available for commonly used twenty-four impedance-pH parameters, their global application has limitations, stemming from use of small healthy volunteer cohorts from few countries for normative data. At present, there is no normative data for twenty-four hours impedance-pH monitoring in Indian population. The aim of this study is to obtain a new set of normal values specific for the Indian population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 13, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

March 3, 2022

Status Verified

February 1, 2022

Enrollment Period

1.6 years

First QC Date

August 4, 2021

Last Update Submit

February 15, 2022

Conditions

Keywords

esophageal diseasesnormative dataReflux disease

Outcome Measures

Primary Outcomes (1)

  • Normative values for impedance-pH monitoring in healthy Indian population.

    There is no normative data for impedance-pH monitoring specific to indian population. The study aims to generate a reference value for the same by enrolling healthy individuals.

    six months

Interventions

24 hour pH impedance monitoring will be done on healthy subjects so that normative data specific to indian population can be generated.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study will enroll only healthy asymtomatic subjects, so that normative data can be generated.

You may qualify if:

  • Healthy individual \> 18 years of age
  • Not on any acid lowering drug from at least 7 days.

You may not qualify if:

  • Thoracic or digestive foregut surgery,
  • Alcohol consumption \>40 g/day,
  • Use of medications that alter intragastric acidity or oesophageal motility
  • History of diabetes mellitus,
  • Neurological disorders
  • Chronic gastrointestinal disease
  • Any subject with upper GI symptoms like pain, burning, belching, bloating, dysphagia \& aerophagia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AIG Hospitals

Hyderabad, Telangana, 500032, India

RECRUITING

Related Publications (4)

  • Sifrim D, Roman S, Savarino E, Bor S, Bredenoord AJ, Castell D, Cicala M, de Bortoli N, Frazzoni M, Gonlachanvit S, Iwakiri K, Kawamura O, Krarup A, Lee YY, Soon Ngiu C, Ndebia E, Patcharatraku T, Pauwels A, Perez de la Serna J, Ramos R, Remes-Troche JM, Ribolsi M, Sammon A, Simren M, Tack J, Tutuian R, Valdovinos M, Xiao Y, Zerbib F, Gyawali CP. Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world. Gut. 2020 Oct 9:gutjnl-2020-322627. doi: 10.1136/gutjnl-2020-322627. Online ahead of print.

  • Roman S, Gyawali CP, Savarino E, Yadlapati R, Zerbib F, Wu J, Vela M, Tutuian R, Tatum R, Sifrim D, Keller J, Fox M, Pandolfino JE, Bredenoord AJ; GERD consensus group. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017 Oct;29(10):1-15. doi: 10.1111/nmo.13067. Epub 2017 Mar 31.

  • Zerbib F, des Varannes SB, Roman S, Pouderoux P, Artigue F, Chaput U, Mion F, Caillol F, Verin E, Bommelaer G, Ducrotte P, Galmiche JP, Sifrim D. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther. 2005 Nov 15;22(10):1011-21. doi: 10.1111/j.1365-2036.2005.02677.x.

  • Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, Zhang X, Adhami T, Murray J, Peters J, Castell D. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004 Jun;99(6):1037-43. doi: 10.1111/j.1572-0241.2004.04172.x.

MeSH Terms

Conditions

Esophageal DiseasesEsophagitisGastroesophageal Reflux

Interventions

Hydrogen-Ion Concentration

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesGastroenteritisEsophageal Motility DisordersDeglutition Disorders

Intervention Hierarchy (Ancestors)

Chemical Phenomena

Study Officials

  • Rakesh kalapala, MBBS, MD, DM

    Senior Consultant

    STUDY DIRECTOR
  • Pradev Inavolu

    Consultant

    PRINCIPAL INVESTIGATOR
  • Hardik Rughwani

    Consultant

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anirrudha P Singh, MBBS, MD, DM

CONTACT

Neeraj Singla, MBBS, MD, DM

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

August 4, 2021

First Posted

August 13, 2021

Study Start

June 1, 2021

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

March 3, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD.

Locations